跳至主要内容
临床试验/NCT01887782
NCT01887782已完成不适用

A Randomized Controlled Study of Conventional Versus Theta Burst Repetitive Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder

Centre for Addiction and Mental Health3 个研究点 分布在 1 个国家目标入组 414 人开始时间: 2013年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
414
试验地点
3
主要终点
HAM-D17 score

研究概览

简要总结

This trial will compare a novel form of rTMS, intermittent Theta Burst Stimulation to the standard conventional high frequency left sided stimulation protocol. The Left dorsolateral prefrontal cortex will be the site of stimulation in both treatment conditions. The site of stimulation will be targeted using MRI co-registration. The study seeks to determine if the two treatment protocols have similar effectiveness in treating major depression.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •outpatients
  • •voluntary and competent to consent
  • •Mini-International Neuropsychiatric Interview (MINI) confirmed diagnosis of MDD, single, recurrent
  • •between ages 18-65
  • •failed to achieve a clinical response to an adequate dose of an antidepressant based on an Antidepressant Treatment History Form (ATHF) score of ≥ 3 in the current episode or have been unable to tolerate at least 2 separate trials of antidepressants of inadequate dose and duration (ATHF 1 or 2)
  • •have a score of ≥ 18 on the HAMD-17 item
  • •have had no increase or initiation of any psychotropic medication in the 4 weeks prior to screening
  • •able to adhere to the treatment schedule
  • •Pass the TMS adult safety screening (TASS) questionnaire
  • •have normal thyroid functioning based on pre-study blood work

排除标准

  • •have a history of substance dependence or abuse within the last 3 months
  • •have a concomitant major unstable medical illness, cardiac pacemaker or implanted medication pump
  • •have active suicidal intent
  • •are pregnant
  • •have a lifetime MINI diagnosis of bipolar I or II disorder, schizophrenia, schizoaffective disorder, schizophreniform, delusional disorder, or current psychotic symptoms
  • •have a MINI diagnosis of obsessive-compulsive disorder, post-traumatic stress disorder (current or within the last year), anxiety disorder (generalized anxiety disorder, social anxiety disorder, panic disorder), or dysthymia assessed by a study investigator to be primary and causing greater impairment than MDD

研究组 & 干预措施

HFL rTMS

Experimental

High Frequency Left repetitive transcranial magnetic stimulation five days per week for 4 weeks

干预措施: HFL rTMS (Device)

iTBS

Active Comparator

intermittent Theta Burst Stimulation (iTBS) five days per week for 4 weeks

干预措施: iTBS (Device)

结局指标

主要结局

HAM-D17 score

时间窗: baseline, after each 5 treatment sessions, and 1, 4, and 12 weeks post-treatment

Outcome measure is measured by a change in the HAM-D17 score from baseline to week 4 or 6. A 50% improvement in the score is considered response to rTMS. A final score of \<8 is categorized as remission.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniel Blumberger

Medical Head, Temerty Centre for Therapeutic Brain Intervention

Centre for Addiction and Mental Health

研究点 (3)

Loading locations...

相似试验